https://www.selleckchem.com/pr....oducts/sorafenib.htm
7%). The detection rates (DR) and false positive rates (FPR) for MVM pathology were similar for the Hadlock (DR=53.1%, FPR=10.8%), WHO (DR=59.4%, FPR=14.2%), and NICHD (DR=53.1%, FPR=12.3%) charts, and each was superior when compared to the IG21 chart (DR=34.4%, FPR=3.8%, p0.001). The diagnosis of SGA was associated with increased risks of preeclampsia and preterm birth for all four charts. The selection of fetal growth chart to be used in screening programs for FGR has important implications with regard to the false positive and
Like
Comment
Share
